Chinook Therapeutics Inc

-0.58 (-3.68%)
Earnings Announcements

Chinook Therapeutics Reports Qtrly Loss Per Share Of $0.69

Published: 11/08/2021 14:32 GMT
Chinook Therapeutics Inc (KDNY) - Chinook Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results.
Qtrly Loss per Share $0.69.
Cash, Cash Equivalents and Marketable Securities Totaled $204.8 Million at September 30, 2021.
Total Revenue Increased by Less Than $0.1 Million for Q3 of 2021.
Q3 Earnings per Share View $-0.84, Revenue View $41670.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.77

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.71

More details on our Analysts Page.